GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,629 GBX | -0.67% |
|
-7.78% | +12.33% |
| 12:02am | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
| Jun. 07 | GSK says FDA Approves Expanded Age Indication For Arexvy, RSV Vaccine For Adults Aged 50-59 At Increased Risk | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 1,708.60 | 1,812.50 | 1,799.50 |
| Spread/Res. | -4.66% | -10.12% | -9.47% |
| Spread/Supp. | +2.87% | +2.87% | +5.99% |
| Support | 1,583.50 | 1,583.50 | 1,537.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
